Edwards Lifesciences (EW) Insider Wayne Markowitz Sells 1,240 Sh
Edwards Lifesciences (EW) insider Wayne Markowitz sold 1,240 shares at $91.47 each, totaling $113,422.80. Over the past year, insiders have sold 37 times with no buys. The company's P/E ratio is 52.17, higher than industry median. GuruFocus values the stock as fairly valued with a GF Value of $94.99.
How this was made
The 30-second read
Why it matters
The insider sale is a modest bearish indicator but is outweighed by the company's growth prospects and valuation considerations.
Market read
Primary source Form 4 filing; small‑scale insider sell adds a cautious tone for EW but unlikely to drive significant price movement.
What to watch
Recent product launches and demographic tailwinds may offset the negative signal from insider divestment.
Background
Edwards Lifesciences is a leading medical device maker focused on structural heart disease and critical care monitoring.
Ticker impact
Insider Wayne Markowitz sold 1,240 shares of Edwards Lifesciences at $91.47 per share, reducing his holding to 20,293.56 shares.
Minor downward pressure; unlikely to move price materially.
Small transaction size relative to market cap and recent insider selling trend indicate a modest bearish signal.
Market effects
Insider selling may raise caution among investors in the medical device sector.
Limited to U.S. equities; no broader regional effect.
Minimal global impact; only relevant to Edwards Lifesciences shareholders.
Counterpoint
Despite insider sales, the company's strong pipeline and high demand for TAVR devices could support price stability.
Key entities
- InsiderWayne Markowitz
Insider who sold 1,240 shares of EW.
- CompanyEdwards Lifesciences Corp
Medical device manufacturer (ticker EW).
